Skip to main content
. 2015 Jan;105(1):212–219. doi: 10.2105/AJPH.2013.301790

TABLE 2—

System Strategies for and Barriers to Colorectal Cancer Screening in Federally Qualified Health Centers in 4 Midwestern States: 2012

All States (n = 44)
Iowa (n = 12)
Minnesota (n = 12)
South Dakota (n = 6)
Wisconsin (n = 14)
Strategy/Barrier No. (%) or % ±SD Valid Responses, No. No. (%) or % ±SD Valid Responses, No. No. (%) or % ±SD Valid Responses, No. No. (%) or % ±SD Valid Responses, No. No. (%) or % ±SD Valid Responses, No.
Policy for CRC screening in place 27* (61) 44 5 (42) 12 11 (92) 12 4 (67) 6 7 (50) 14
 Written policy 14 (52) 27 2 (40) 5 7 (64) 11 3 (75) 4 2 (29) 7
EMRs used 34 (79) 43 6 (50) 12 11 (92) 12 5 (100) 5 12 (86) 14
 EMR can query patients due for CRC screening 23 (68) 34 5 (83) 6 8 (73) 11 3 (60) 5 7 (58) 12
 EMR can query whether patients are up-to-date for CRC screening 19 (61) 31 5 (83) 6 7 (70) 10 2 (50) 4 5 (45) 11
Items routinely checked during patient visits
 CRC screening completed 25 (61) 41 8 (73) 11 5 (45) 11 4 (67) 6 8 (62) 13
 History of ulcerative colitis or Crohn’s disease 10 (25) 40 3 (30) 10 3 (27) 11 2 (33) 6 2 (15) 13
 Immediate family with CRC or polyps 27 (66) 41 9 (82) 11 7 (64) 11 5 (83) 6 6 (46) 13
 Distant relative with CRC or polyps 18 (44) 41 7 (64) 11 4 (36) 11 3 (50) 6 4 (31) 13
Clinic personnel help to encourage screening 26 (59) 44 9 (75) 12 7 (58) 12 2 (33) 6 8 (57) 14
CRC screening offered to patients aged ≥ 50 y
 FOBT 34 (77) 44 11 (92) 12 10 (83) 12 5 (83) 6 8 (57) 14
 FIT 18* (41) 44 1 (8) 12 5 (42) 12 4 (67) 6 8 (57) 14
 Flexible sigmoidoscopy 5 (11) 44 2 (17) 12 2 (17) 12 0 (0) 6 1 (7) 14
 Colonoscopy 28 (64) 44 7 (58) 12 9 (75) 12 3 (50) 6 9 (64) 14
FOBT or FIT provided to patients aged ≥ 50 y 41 (93) 44 9 (75) 12 12 (100) 12 6 (100) 6 14 (100) 14
 Test return tracked 26 (63) 41 6 (67) 9 7 (58) 12 5 (83) 6 8 (57) 14
 Patient called if test not returned 12 (34) 35 3 (38) 8 5 (63) 8 1 (17) 6 3 (23) 13
 Patient contacted by mail if test not returned 9 (26) 35 3 (38) 8 3 (38) 8 1 (17) 6 2 (15) 13
 Patient offered colonoscopy after positive test 38 (97) 39 9 (100) 9 11 (100) 11 5 (100) 5 13 (93) 14
 System in place to offer FOBT annually 20 (54) 37 3 (43) 7 6 (55) 11 3 (60) 5 8 (57) 14
CRC screening offered to patients aged ≤ 50 y if risk factors present 38 (86) 44 10 (83) 12 11 (92) 12 5 (83) 6 12 (86) 14
 FOBT 25* (66) 38 9 (90) 10 6 (55) 11 5 (100) 5 5 (42) 12
 FIT 14 (37) 38 1 (10) 10 4 (36) 11 3 (60) 5 6 (50) 12
 Flexible sigmoidoscopy 4 (11) 38 2 (20) 10 0 (0) 11 1 (20) 5 1 (8) 12
 Colonoscopy 26 (68) 38 7 (70) 10 7 (64) 11 3 (60) 5 9 (75) 12
 Patients referred for colonoscopy 43 (98) 44 12 (100) 12 12 (100) 12 6 (100) 6 13 (93) 14
Main barriers to providing CRC screening
 Lack of time 18 (41) 44 7 (58) 12 3 (25) 12 2 (33) 6 6 (43) 14
 Lack of funding for FOBT 7 (16) 44 4 (33) 12 0 (0) 12 0 (0) 6 3 (21) 14
 Lack of time for personnel to explain test 10 (23) 44 5 (42) 12 1 (8) 12 0 (0) 6 4 (29) 14
 Language 12* (27) 44 6 (50) 12 4 (33) 12 2 (33) 6 0 (0) 14
 Lack of appropriate patient education material 12 (27) 44 4 (33) 12 4 (33) 12 1 (17) 6 3 (21) 14
 Inability to provide colonoscopy for patients with positive FOBT or FIT 26 (59) 44 9 (75) 12 6 (50) 12 2 (33) 6 9 (64) 14
 Inability to provide colonoscopy for patients with colon symptoms 24 (55) 44 7 (58) 12 6 (50) 12 2 (33) 6 9 (64) 14
 No CRC screening tracking system 18 (41) 44 7 (58) 12 2 (17) 12 2 (33) 6 7 (50) 14
Patients with up-to-date CRC screening 34.94 ±21.01 33 30.27 ±21.33 11 34.0 ±22.70 8 38.0 ±25.15 5 39.78 ±19.17 9

Note. CRC = colorectal cancer; EMR = electronic medical record; FIT = fecal immunochemical test; FOBT = fecal occult blood test. Denominator for all percentages is respective number of valid responses.

*P ≤ .05 (Fisher exact test).